Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Reducing Operative Blood Loss in Laparoscopic Myomectomy With Umbilico-uterine Trunk Clipping

NCT07200778 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-09-11
Last updated
2025-10-07

Condition(s) studied

Laparoscopic Myomectomy

Investigational drug(s) / intervention(s)

umbilico-uterine trunk occlusionlocal epinephrine infiltration

umbilico-uterine trunk occlusion: participants will undergo umbilico-uterine trunk occlusion during laparoscopic myomectomy

local epinephrine infiltration: participants will undergo local injections of epinephrine into the serosal and/or myometrium, covering the myoma before the uterine incision during laparoscopic myomectomy

Study summary

the purpose of this study is to examine how Umbilico-uterine trunk occlusion reduces surgery-associated blood loss in Laparoscopic Myomectomy.

Eligibility

Sex
FEMALE
Min age
19 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 19 and 45 * Symptoms of menorrhagia, pelvic pain, or infertility * Plan to have a laparoscopic myomectomy * Number of myomas ≤ 4, with the largest myoma measuring ≤ 9 cm Exclusion Criteria: * Postmenopausal status * Dominant pedunculated subserosal FIGO classification (6-7) * Submucosal type of myoma FIGO classification (0-2) * Suspicion of malignant uterine or adnexal diseases * Major medical comorbidities or psychiatric illnesses that could affect follow-up and/or compliance * Refusal to participate or provide consent to the procedures.

Primary outcome measure(s)

  • Operative Blood Loss — during operation
    The difference between the total amount of irrigation and suction will be used to compute operational blood loss
  • Hemoglobin drop — 24 hours postoperative
    The difference between the preoperative and postoperative hemoglobin levels will be used to define the hemoglobin change.

Trial sites (1)

FacilityCityRegionStatus
Minia advanced laparoscopy unit Minya Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07200778 on ClinicalTrials.gov ↗ ← All trials in Egypt